Oppenheimer upgraded shares of Transcat (NASDAQ:TRNS – Free Report) from a market perform rating to an outperform rating in a report published on Wednesday morning, MarketBeat.com reports. They currently have $115.00 price target on the scientific and technical instruments company’s stock. Other equities research analysts also recently issued research reports about the stock. CJS Securities […]